These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11499257)

  • 1. [Can Sartane help a failing heart? AT1-receptor antagonists in cardiac insufficiency].
    Düsing R
    Pharm Unserer Zeit; 2001; 30(4):314-20. PubMed ID: 11499257
    [No Abstract]   [Full Text] [Related]  

  • 2. [Application to the internist practice. The place of AT1 receptor antagonists].
    Dusleag H
    Pharm Unserer Zeit; 2001; 30(4):322-5. PubMed ID: 11499258
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin II type 1 receptor blockers and congestive heart failure.
    Auer JW; Berent R; Eber B
    Circulation; 2001 Oct; 104(15):E82. PubMed ID: 11591633
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of losartan on haemodynamic parameters and angiotensin receptor mRNA levels in rat heart after myocardial infarction.
    Zhu YZ; Zhu YC; Li J; Schäfer H; Schmidt W; Yao T; Unger T
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):257-62. PubMed ID: 11881034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are angiotensin II receptor antagonists indicated in chronic heart failure?
    Komajda M
    Heart Fail Monit; 2002; 2(3):85-7. PubMed ID: 12634889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure].
    Vizir VA; Berezin AE
    Ter Arkh; 2002; 74(1):52-5. PubMed ID: 11878061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor antagonists: enlarging therapeutic possibilities in arterial hypertension.
    Plante GE
    Can J Cardiol; 1999 Nov; 15 Suppl F():4F-6F. PubMed ID: 10579746
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT?
    McMurray JJ
    J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):89-92. PubMed ID: 11881104
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP; Rumley A; Lowe GD; McMurray JJ
    Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract]   [Full Text] [Related]  

  • 10. [German Hypertension League on the LIFE Study. New evaluation of AT1 receptor antagonists].
    Dominiak P; Zidek W
    MMW Fortschr Med; 2002 Sep; 144(38):47. PubMed ID: 12395703
    [No Abstract]   [Full Text] [Related]  

  • 11. [ESC guidelines for therapy of heart failure. AT1 blockers are now also included].
    MMW Fortschr Med; 2002 Jan; 144(3-4):62. PubMed ID: 11862800
    [No Abstract]   [Full Text] [Related]  

  • 12. [The outlook for the use of the nonpeptide angiotensin II-receptor antagonist losartan in treating heart failure].
    Dunaev VV; Berezin AE
    Eksp Klin Farmakol; 1999; 62(4):77-80. PubMed ID: 10513345
    [No Abstract]   [Full Text] [Related]  

  • 13. [Isolated systolic hypertension. "AT1 blocker preferred over beta-blocker"].
    MMW Fortschr Med; 2002 Sep; 144(38):14. PubMed ID: 12395694
    [No Abstract]   [Full Text] [Related]  

  • 14. [ACE-inhibitors, AT1 receptor antagonists and diastolic dysfunction].
    Metra M; Nodari S; Bordonali T; Cagnazzi E; Boldi E; Dei Cas L
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):53-8. PubMed ID: 12497882
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].
    Sandmann S; Unger T
    Drugs; 2002; 62 Spec No 1():43-52. PubMed ID: 12036388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacologic basics: the effect of AT1 receptor antagonists].
    Altmannsberger SH; Paneitz A; Siegmund W; Kroemer HK
    Pharm Unserer Zeit; 2001; 30(4):296-302. PubMed ID: 11499254
    [No Abstract]   [Full Text] [Related]  

  • 17. [The race for a new target. The human AT1 receptor].
    Gurrath M
    Pharm Unserer Zeit; 2001; 30(4):288-95. PubMed ID: 11499253
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-epsilon in acutely reperfused myocardial infarction in the dog. Effect of UP269-6 and losartan on AT1 and AT2-receptor expression and IP3 receptor and PKCepsilon proteins.
    Xu Y; Menon V; Jugdutt BI
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):184-95. PubMed ID: 11967812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympatho-inhibitory properties of various AT1 receptor antagonists.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Losartan--a nonpeptide antagonist of angiotensin-II receptors in the treatment of heart failure].
    Berezin AE; Fushteĭ IM
    Klin Med (Mosk); 1998; 76(7):12-5. PubMed ID: 9742770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.